NAS:RDUS (USA) Also Trade In: Germany
Radius Health Inc $ 11.78 0.12 (0.99%)
Warning! GuruFocus has detected 4 Severe warning signs with RDUS. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for RDUS (Radius Health Inc) from 2014 to Sep 22 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Radius Health stock (RDUS) PE ratio as of Sep 22 2020 is 0. More Details
Radius Health PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Radius Health PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:DRRX NAS:RLMD NAS:AERI NAS:AVDL NAS:EGRX NAS:NLTX NAS:COLL NAS:ANIP NAS:FLXN NAS:PETQ NYSE:ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Address 950 Winter Street, Waltham, MA, USA, 02451
Radius Health Inc is an integrated biopharmaceutical company. It develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company's product, TYMLOS, is for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The product pipeline of the company includes Abaloparatide-patch for the treatment of postmenopausal women with osteoporosis, Elacestrant, and RAD140. It primarily operates the business in the United States of America and generates key revenue from the sales of TYMLOS.